iShares 3 7 Year Treasury Bond ETF (IEI) Stock Price Today
Key Stats
- -MARKET_CAP
- -VOLUME
- Fixed IncomeSECTOR
- $120.72FIFTY_TWO_WEEK_HIGH
- $116.67FIFTY_TWO_WEEK_LOW
- -TYPICAL_HOLD_TIME
- -ENTERPRISE_VALUE
- -DIVIDEND_YIELD
- -TRADING_ACTIVITY
Track iShares 3 7 Year Treasury Bond ETF (IEI) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, iShares 3 7 Year Treasury Bond ETF has traded between a low of $116.63 and a high of $120.72, highlighting its annual price range. Buy and sell iShares 3 7 Year Treasury Bond ETF shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About iShares 3 7 Year Treasury Bond ETF
IEI tracks the ICE U.S. Treasury 3-7 Year Bond Index, offering exposure to intermediate-term government debt. It serves as a conservative middle ground in the Treasury yield curve, providing higher yields than short-term bills with less volatility than long-term bonds.
Most Recent News
Global green hydrogen market to reach $188.9B by 2035, growing at 31.2% CAGR driven by industry and transport demand.
The global green hydrogen market, valued at $12.5 billion in 2025, is projected to grow to $188.9 billion by 2035 at a 31.2% CAGR. Growth is driven by industries like steel and chemicals seeking low-carbon alternatives, and the rising adoption of hyd...

Investigation launched into Abundia Global Impact Group's board for potential fiduciary breaches.
Abbott Cooper PLLC is investigating whether Abundia Global Impact Group's board of directors breached fiduciary duties or committed wrongdoing. The investigation concerns stockholders who have held shares since July 1, 2025, or earlier. Abundia's sha...

Investigation launched into Estrella Immunopharma's board for possible fiduciary breaches
Abbott Cooper PLLC has initiated an investigation on behalf of Estrella Immunopharma, Inc. stockholders to determine if the company's board of directors violated fiduciary duties or engaged in wrongdoing. Estrella's stock trades on Nasdaq under the s...
